GlassScriptPhysician profile
Vel Sivapalan
NPI 1427005255
$1,749.31
in general payments reported to CMS, 2019-2025
6 companies · $821 in 2025
The $821 reported for 2025 was more than what 95% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.76 · 2020: $22.17 · 2021: $90.37 · 2022: $228 · 2023: $241 · 2024: $309 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $690 · Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $690.00 |
| Food and Beverage | $681.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,384.24 | 2020-2025 | Cabenuva, Dovato, Apretude |
| Merck Sharp & Dohme LLC | $161.02 | 2022-2025 | Zerbaxa, Prevymis |
| Gilead Sciences, INC. | $89.40 | 2019-2025 | Yeztugo |
| Embecta Corp. | $62.70 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Abbvie INC. | $27.39 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $24.56 | 2024 | Vibativ |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vel Sivapalan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.